Renmin Hospital of Wuhan University University
Recent work (1): Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients.
Recent work (2): Clinical characteristics and death risk factors in severe novel coronavirus pneumonia (COVID-19) patients: a single-center respective analysis based on medical records. Recent work (3): Investigation for the sleep quality in non-health care workers during the pandemic of novel coronavirus pneumonia (COVID-19). Recent work (4): Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19).
Recent work (2): Clinical characteristics and death risk factors in severe novel coronavirus pneumonia (COVID-19) patients: a single-center respective analysis based on medical records. Recent work (3): Investigation for the sleep quality in non-health care workers during the pandemic of novel coronavirus pneumonia (COVID-19). Recent work (4): Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19).
Technology:
COVID Labs/Universities
Industry:
COVID R&D
Headquarters:
China
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership